Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

177.80
+3.051.75%
Post-market: 177.800.00000.00%16:10 EDT
Volume:1.65M
Turnover:291.85M
Market Cap:23.86B
PE:-50.75
High:179.17
Open:173.32
Low:172.00
Close:174.75
52wk High:183.51
52wk Low:60.45
Shares:134.20M
Float Shares:129.78M
Volume Ratio:1.02
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-107.06
PE(LYR):-53.55

Loading ...

Guardant Health FDA Win Sparks Interest In Liquid Biopsy Valuation Gap

Simply Wall St.
·
May 27

Guardant Health Chief Commercial Officer Chris Freeman disposes of 24,406 common shares worth $2.9 million

Reuters
·
May 27

Guardant Health Is Maintained at Buy by BTIG

Dow Jones
·
May 26

Guardant Health Inc : Btig Raises Target Price to $155 From $145

THOMSON REUTERS
·
May 26

Assessing Guardant Health (GH) Valuation After A Strong Share Price Run

Simply Wall St.
·
May 24

Guardant Health Chief Legal Officer John G. Saia sells USD 2.11 million common shares

Reuters
·
May 23

Guardant Health Co-CEO AmirAli Talasaz disposes of shares worth $22.18 million

Reuters
·
May 23

Guardant Health director Ian T. Clark disposes of shares worth $735,048.53

Reuters
·
May 23

Guardant Health director Manuel Hidalgo Medina disposes 1,250 shares worth $133,384.38

Reuters
·
May 23

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

GlobeNewswire
·
May 23

Movement Alert|Guardant Health Falls 8.48% in Pre-Market Trading, Pulling Back After FDA Approval-Driven Rally

Market Focus
·
May 22

Movement Alert|Guardant Health Rises 5.01% in Regular Trading, Liquid Biopsy Test Receives FDA Approval

Market Focus
·
May 21

GH Research to Present New GH001 Phase 2b Data in Treatment-Resistant Depression at ASCP 2026

TIPRANKS
·
May 21

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and OS Therapies Incorporated (OSTX)

TIPRANKS
·
May 21

Movement Alert|Guardant Health Rises 10.09% in Regular Trading, FDA Approves Next-Generation Liquid Biopsy Test

Market Focus
·
May 21

FDA approves Guardant360 Liquid CDx test for Guardant Health

Reuters
·
May 20

FDA Approves New Guardant360 Liquid Cdx, the Largest FDA-Approved Liquid Biopsy Panel With a 100X Expanded Footprint

THOMSON REUTERS
·
May 20

Judge sanctions law firm Quinn Emanuel, citing ethical lapses

Reuters
·
May 20

Guardant Health director Tariq Musa disposes of USD 11,131.36 in shares

Reuters
·
May 20

GH Research Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 19